Susan Mayor. Show Affiliations »
Abstract
Mesh: See more » Antibodies, Monoclonal/therapeutic useClinical Trials, Phase I as TopicCombined Modality TherapyHumansIpilimumabMelanoma/drug therapyMelanoma/pathologyMelanoma/radiotherapyNeoplasm Metastasis
Substances: See more » Antibodies, MonoclonalIpilimumab
Year: 2015 PMID: 25773169 DOI: 10.1016/S1470-2045(15)70118-X
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316